openPR Logo
Press release

United States Point-of-Care Lipid Test Market to Reach USD 1.23 Billion by 2033, Driven by Preventive Healthcare and Rapid Testing Demand | DataM Intelligence

10-21-2025 12:02 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Point-of-Care Lipid Test Market

Point-of-Care Lipid Test Market

The global Point-of-Care Lipid Test Market reached USD 0.72 billion in 2024 and is projected to reach USD 1.23 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, Abbott Laboratories received FDA clearance for its new rapid lipid panel test providing results in under 5 minutes.
✅ In October 2025, The American Heart Association updated guidelines recommending routine point-of-care lipid testing in primary care settings.
✅ In October 2025, A major US retail pharmacy chain implemented lipid testing stations in 2,000 locations, increasing patient access to cardiovascular screening.

Japan: Recent Industry Developments

✅ In October 2025, Roche Diagnostics launched a compact lipid testing device with cloud connectivity for remote patient monitoring.
✅ In October 2025, Japan's Ministry of Health approved point-of-care lipid testing for workplace health screenings nationwide.
✅ In October 2025, Sysmex Corporation developed a multi-parameter testing system integrating lipid profiles with other cardiovascular risk markers.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/point-of-care-poc-lipid-test-market?jd

Market Trends & Drivers

The Point-of-Care Lipid Test Market is experiencing significant growth driven by the rising prevalence of cardiovascular diseases, increasing focus on preventive healthcare, and technological advancements in rapid testing. Key trends include the development of multi-parameter testing devices, integration with electronic health records, and expansion into non-traditional healthcare settings. The growing emphasis on early cardiovascular risk detection, convenience of rapid results, and rising healthcare consumerism are significantly accelerating market adoption across various care settings.

Competitive Landscape

The market features strong competition among diagnostic companies and medical device manufacturers specializing in rapid testing technologies.

Abbott Laboratories leads with its Afinion and i-STAT systems for rapid lipid profiling and cardiovascular risk assessment.
Roche Diagnostics offers the Cobas h 232 system and other POC solutions for lipid testing and cardiac risk management.
Siemens Healthineers provides rapid lipid testing through its DCA Vantage and epoc blood analysis systems.
Quest Diagnostics expands its POC offerings with rapid lipid testing services in retail and workplace settings.
PTS Diagnostics specializes in CardioChek and other point-of-care lipid testing devices for professional and consumer use.
Beckman Coulter, Inc. (Danaher) develops rapid testing solutions for lipid profiles and cardiovascular risk assessment.
Alere Inc. (Abbott) offers rapid lipid testing technologies for various healthcare settings and applications.
Instrumentation Laboratory provides point-of-care testing solutions including lipid profile analysis.
Nova Biomedical develops whole blood analyzers with lipid testing capabilities for point-of-care settings.
ACON Laboratories, Inc. manufactures rapid test strips and readers for cholesterol and lipid panel testing.

Segmentation

By Product Type (Instruments, Consumables)
By Disease Indication (Hyperlipidemia, Hypercholesterolaemia, Tangier Disease, Hyperlipoproteinemia, Familial Hypercholesterolemia, Others)
By Application (Research and Development, Diagnostics, Biotechnological Product Manufacturing, Agriculture, Others)
By End-User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organizations (CDMOs), Diagnostic Laboratories & Clinical Research Centers, Others)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/point-of-care-lipid-test-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Point-of-Care Lipid Test Market to Reach USD 1.23 Billion by 2033, Driven by Preventive Healthcare and Rapid Testing Demand | DataM Intelligence here

News-ID: 4232548 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031, Driven by Supplements and Functional Foods Demand | DataM Intelligence
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading companies - Toyal America Inc, Hunan Ningxiang Jiweixin Metal Powder Co., Ltd., ECKA Granules
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad United States: Recent Industry
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billion by 2033 | Leading companies - Bayer AG, Haleon group of companies, Kenvue, Teva Pharmaceutical Industries Ltd
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market. Download your exclusive sample report today: (corporate email gets priority access):
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading companies - Alnylam Pharmaceuticals, Inc., NOVARTIS AG, Sarepta Therapeutics, Inc.
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market. Download your exclusive sample report today: (corporate

All 5 Releases


More Releases for Lipid

Key Trends Shaping the Future Lipid Market From 2025-2034: Advancements In Scala …
What industry-specific factors are fueling the growth of the lipid market? The lipid market's expansion is projected to be fuelled by a growing demand for nutritional supplements. The increase in nutritional requirements resulting from a more active lifestyle or health condition is often met with supplementation. Lipid-based nutrient supplements - those where lipids supply the majority of the energy and also encompass protein, energy, essential fatty acids, and micronutrients - play
Lipid-Nanoparticle Based Genomic Medicines Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Lipid-Nanoparticle Based Genomic Medicines Market - (By Type (Liposome-based Nanoparticles, Micelle-based Nanoparticles, Lipid-Coated Nanoparticles), By Application (Cancer Treatment, Infectious Diseases, Genetic Disorders, Cardiovascular Diseases, Others), By Therapeutic Payload (mRNA-based Therapeutics, siRNA-based Therapeutics, miRNA-based Therapeutics, Other Genomic Medicines), By End-User (Hospitals, Biopharmaceutical Companies, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the
Lipid Regulators Market Report 2024 - Lipid Regulators Market Trends And Growth
"The Business Research Company recently released a comprehensive report on the Global Lipid Regulators Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Lipid Research: Creative Biolabs Launches Its Lipid-Based Delivery Solutions
Creative Biolabs, a leading biotechnology company, unveiled its latest solutions for developing lipid-based delivery systems last week. New York, USA - April 18, 2024 - "Liposomes as excellent drug delivery vehicles continuously drive innovation in drug delivery development and open up new breakthroughs and possibilities. Building on this momentum, we have designed a suite of solutions for lipid-based delivery system development," said an expert from the Lipid Research Department, Creative Biolabs. Image:
Creative Biolabs: Unlocking Lipid Biology With Complete Lipid Analysis Solutions
Creative Biolabs, a pioneer in the field of biotechnology, is delighted to announce the launch of cutting-edge assay and analysis solutions tailored specifically for liposome drug delivery. New York, USA - March 26, 2024 - Liposomes, versatile lipid-based structures, have emerged as promising carriers for drug delivery due to their biocompatibility, flexibility, and capacity to encapsulate a wide range of therapeutics. To ensure the successful development of lipid-based drug delivery systems,
Lipid Nanoparticles (LNP) Market Growth Is Attributed To The Increasing Demand F …
According to Precision Business Insights (PBI) latest report, the Lipid Nanoparticles (LNP) Market size is expected to be worth USD 675.0 Million in 2022, growing at a 7.5% CAGR from 2022 to 2028. The growing demand for therapeutic drugs and vaccinations to combat viral illnesses like Ebola, influenza, HIV, and other viruses, together with the traditional vaccine approach's failure to find vaccines in time for a crisis, are all contributing